TFS
New York, US · Founded 2017
Founders & leadership
AW
Annafi WahedCEO, Director, and Co-Founder
JV
Jihan VariscoCOO and Co-Founder
Reported raises · per SEC filings
Form D private placements$125KraisedFeb 2023 · 2 investors · Other Technology
Rule 506(b)$500KraisedDec 2019 · 1 investors · Other
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Acquisitions · 2
Early investors' stakes continue via these dealsSantalis Pharmaceuticals, Inc.
Develops botanical healthcare products using sustainable sandalwood oil (EISO); acquired by TFS Corporation in 2015.
ViroXis Corporation, Inc.
Mid-stage drug developer of botanical anti-viral topical prescription candidates for skin diseases; acquired by TFS Corporation in 2017.